|
Iqbal Grewal joined Seattle Genetics in October 2004. He manages the company’s molecular oncology and immunology, translational biology and pharmacology and toxicology functions, including the planning and execution of studies to advance preclinical programs and support clinical development activities. Prior to joining Seattle Genetics, Dr. Grewal was with Genentech as a Senior Scientist in the Department of Immunology. He joined Genentech in May 1998, where he managed discovery research programs responsible for identifying and validating novel molecules for therapeutic use in the areas of oncology and autoimmune disease. In addition, he was a project leader on teams that conducted extensive studies of preclinical candidates for product development. Prior to Genentech, Dr. Grewal worked at Yale University School of Medicine. Before that, he held various research positions at the University of California, Los Angeles (UCLA). Dr. Grewal holds a B.S. in Biology and Chemistry from Panjab University in India, a M.S. in Immunobiology from the University of Aberdeen in the United Kingdom and a Ph.D. in Immunology from UCLA. He has published over 80 manuscripts and co-authored several patent applications.
| 